Snap CTO Divests $10.6M in Shares as Stock Hits Historic Low

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Snap's CTO sold $10.6M in shares as stock hits all-time low of $4.72, amid weak revenue guidance and continued losses in competitive ad market.

Snap CTO Divests $10.6M in Shares as Stock Hits Historic Low

Snap Inc.'s Chief Technology Officer Robert C. Murphy executed a substantial share sale, divesting 2 million shares valued at approximately $10.63 million, as the company's stock price declined to an all-time low of $4.72 per share. The transaction marks a significant insider sale during a period of notable weakness for the social media platform's equity.

The share sale comes amid a challenging operating environment for Snap, which continues to navigate profitability headwinds despite reducing net losses on a year-over-year basis. The company operates within an intensely competitive digital advertising marketplace dominated by larger rivals Meta and TikTok, pressuring both revenue growth and margin expansion.

Adding to investor concerns, Snap's first-quarter 2026 revenue guidance fell short of analyst consensus expectations, contributing to downward momentum in the stock. The confluence of near-term guidance disappointment and persistent net losses has created sustained selling pressure on the company's shares throughout recent trading sessions.

Source: The Motley Fool

Back to newsPublished Feb 16

Related Coverage

The Motley Fool

Arm Makes Historic Entry Into AI Silicon With New AGI CPU, Lands Meta, OpenAI as Partners

Arm Holdings launches its first physical AI chip, the AGI CPU, with twice the efficiency of x86 rivals. Meta, OpenAI, and Cloudflare are among inaugural customers.

NVDAMETAMSFT
The Motley Fool

Nebius Eyes $7-9B Revenue by 2026 as AI Cloud Growth Accelerates

Nebius reports 547% YoY revenue growth to $228M in Q4, projects $7-9B ARR by 2026, but operates at major losses amid data center expansion.

NVDAMETAMSFT
GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
The Motley Fool

SMR Potential vs. Proven Profits: NuScale and Constellation Battle for Nuclear Leadership

NuScale offers higher growth potential as the only approved SMR designer but faces years before revenue. Constellation Energy provides profitable operations, Microsoft/Meta contracts, and a growing dividend—making it the more prudent choice.

SMRMETAMSFT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS